SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000215457-17-002986
Filing Date
2017-04-10
Accepted
2017-04-10 12:00:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 anthera.pharmaceut.txt SC 13G/A 10441
  Complete submission text file 0000215457-17-002986.txt   12175
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Subject) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85368 | Film No.: 17752439
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies